Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Collagen aggregate composite medical fiber with antibacterial/antibacterial function

An aggregate and composite technology, which is applied in the chemical characteristics of fibers, cellulose/protein conjugated rayon, and conjugated rayon, etc., can solve the problems of affecting the application of materials, poor spinnability of collagen, and difficulty in spinning. , to achieve the effect of being convenient for large-scale promotion and use, high chemical reactivity, and ensuring biocompatibility

Active Publication Date: 2016-08-17
SICHUAN UNIV
View PDF7 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] 1. Collagen itself has poor spinnability and is not easy to spin;
[0004] 2. The mechanical strength of collagen-based composite fibers is generally poor, and the biodegradation performance is too fast to meet the metabolic needs of the body. At the same time, its structural stability is also poor, and it is easily affected by the external environment
[0005] In order to make up for the above shortcomings, researchers generally immerse the composite fibers prepared by wet spinning in an acetalization bath (mainly composed of formaldehyde and glutaraldehyde) to modify them, resulting in a significant decline in the biocompatibility of the material. And has potential toxicity, which directly affects the application of materials

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] (1) Preparation of acid-soluble collagen aggregates: take 1 part by weight of collagen aggregates, grind and pulverize them into flocs on a grinder, and then immerse them in 1 volume part of a buffer solution with a pH of 9.0, Stir for 5 hours at a temperature of 4°C, take the collagen aggregates out of the solution and drain them, then pour the collagen aggregates and 0.05 parts by weight of sodium epoxypropanesulfonate into a supercritical carbon dioxide reactor at the same time , reacted at a temperature of 30°C and a pressure of 8Mpa for 2 hours. After the end, the cross-linked collagen aggregates were taken out, soaked in PBS buffer and deionized water for 5 hours, and finally freeze-dried to make acid-soluble collagen aggregates;

[0031](2) Preparation of bisaldehyde carboxymethylcellulose sodium: Pour 1 weight part of carboxymethylcellulose sodium and 20 volume parts of acetic acid-sodium acetate buffer solution with a pH of 3.0 into the reaction kettle at the s...

Embodiment 2

[0035] (1) Preparation of acid-soluble collagen aggregates: take 1.5 parts by weight of collagen aggregates, grind and pulverize them into flocs on a grinder, and then immerse them in 15 parts by volume of a buffer solution with a pH of 10.5, Stir for 8 hours at a temperature of 5°C, take out the above-mentioned collagen aggregates from the solution in a clean room, drain, and then pour the above-mentioned collagen aggregates and 0.1 parts by weight of succinic anhydride into a supercritical carbon dioxide reactor at the same time, React for 12 h at a temperature of 35 °C and a pressure of 10 MPa. After the end, the cross-linked collagen aggregates were taken out, soaked in PBS buffer and deionized water for 8 h, and finally freeze-dried to make acid-soluble collagen aggregates;

[0036] (2) Preparation of bisaldehyde carboxymethylcellulose sodium: Pour 1.5 parts by weight of sodium carboxymethylcellulose and 30 parts by volume of acetic acid-sodium acetate buffer solution wit...

Embodiment 3

[0040] (1) Preparation of acid-soluble collagen aggregates: Take 2 parts by weight of collagen aggregates, grind and pulverize them into flocs on a grinder, and then immerse them in 20 parts by volume of a buffer solution with a pH of 11.5, Stir for 10 hours at a temperature of 10°C, take the collagen aggregates out of the solution and drain them, then pour the collagen aggregates and 0.2 parts by weight of sodium epoxypropylene sulfonate into a supercritical carbon dioxide reactor at the same time , reacted for 48 h at a temperature of 45 °C and a pressure of 15 MPa. After the end, the cross-linked collagen aggregates were taken out, soaked in PBS buffer and deionized water for 10 h, and finally freeze-dried to make acid Soluble collagen aggregates;

[0041] (2) Preparation of bisaldehyde carboxymethylcellulose sodium: Pour 2 parts by weight of sodium carboxymethylcellulose and 50 parts by volume of acetic acid-sodium acetate buffer solution with a pH of 5.0 into the reaction...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
elongation at breakaaaaaaaaaa
Login to View More

Abstract

The invention discloses a collagen aggregate compound medical fiber with an antibacterial / bacteriostatic function. The collagen aggregate compound medical fiber is characterized in that collagen aggregate is taken as a raw material, supercritical CO2 is taken as a medium, and epoxy sodium propyl sulfonate or anhydride is taken as a modifying agent, so that acid-soluble collagen aggregate can be obtained; carboxymethyl cellulose is taken as a raw material, and sodium periodate is taken as an oxidizing agent, so that dialdehyde carboxymethyl cellulose can be obtained; the acid-soluble collagen aggregate, the dialdehyde carboxymethyl cellulose and chitin are organically mixed, and the collagen aggregate compound medical fiber can be finally prepared by the technological processes of stirring, standing and defoaming, spinning and the like. The fiber material has good biological performance, biodegradability and biodegradability of the collagen aggregate as well as excellent antibacterial / bacteriostatic activity and anti-inflammation / wound healing promotion function of the chitin; all the performances of the collagen aggregate compound medical fiber are obviously superior to those of the collagen matrix composite fiber material prepared by taking common collagen as a raw material; the collagen aggregate compound medical fiber can be taken as a biological dressing, a hemostatic material, an absorbable suture, a medical face-lifting material, and the like.

Description

technical field [0001] The invention relates to a collagen aggregate composite medical fiber with antibacterial / antibacterial functions, belonging to the field of biomedical materials. Background technique [0002] Collagen has been proven to be a biomedical material with excellent comprehensive performance. Collagen-based composite materials prepared by organically compounding it with other natural / synthetic polymer biomedical materials have always been a hot spot and difficulty in the field of collagen research. Collagen and Its composite materials have been made into different dosage forms such as gel, solution, sponge, granule, fiber and biofilm, and are widely used in biomedical fields such as tissue engineering scaffolds, biological dressings, hemostatic materials, and medical sutures. In particular, the preparation of collagen or its composite materials into medical functional fibers by wet spinning has attracted extensive attention from researchers, and some medical ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): D01F8/02D01F8/18
Inventor 但卫华刘新华但年华龚居霞
Owner SICHUAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products